Literature DB >> 18575952

Cancer in systemic lupus: what drives the risk?

Sasha Bernatsky, A E Clarke, R Ramsey-Goldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18575952     DOI： 10.1007/s10552-008-9191-0

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN： 0957-5243            Impact factor:   2.506


× No keyword cloud information.
  3 in total

1.  Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls.

Authors:  Darren R Brenner; Paul Brennan; Paolo Boffetta; Christopher I Amos; Margaret R Spitz; Chu Chen; Gary Goodman; Joachim Heinrich; Heike Bickeböller; Albert Rosenberger; Angela Risch; Thomas Muley; John R McLaughlin; Simone Benhamou; Christine Bouchardy; Juan Pablo Lewinger; John S Witte; Gary Chen; Shelley Bull; Rayjean J Hung
Journal:  Hum Genet       Date:  2013-02-01       Impact factor: 4.132

2.  [Secondary immunodeficiency in rheumatological diseases].

Authors:  D Ernst; R E Schmidt; T Witte
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372

Review 3.  Cyclophosphamide and lupus nephritis: when, how, for how long?

Authors:  Stella Ntali; George Bertsias; Dimitrios T Boumpas
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.